SearchDictionaryMobileLogin

Markku Laakso Selected Research

Type 2 Diabetes Mellitus (MODY)

03/2008Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study.
04/2007Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
07/2006Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
03/2005The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
05/2004The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
01/2004Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus.
07/2003Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.
06/2002Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Articles by Research Topic

Disease

8Type 2 Diabetes Mellitus (MODY)
03/2008 - 06/2002
7Coronary Disease (Coronary Heart Disease)
03/2007 - 03/2002
4Syndrome
03/2008 - 12/2004
4Hypertrophic Cardiomyopathy (Asymmetric Septal Hypertrophy)
05/2007 - 01/2003
3Insulin Resistance
02/2008 - 03/2004
3Pre-Eclampsia (Preeclampsia)
09/2006 - 10/2002
3Obesity
07/2006 - 07/2003
3Alzheimer Disease (Alzheimer's Disease)
01/2006 - 01/2002
3Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
12/2004 - 12/2003
2Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
09/2005 - 09/2004
2Cardiovascular Diseases (Cardiovascular Disease)
07/2003 - 01/2003
1Heart Failure
04/2008
1Hyperglycemia
02/2008
1Atherosclerosis (Atheroma)
10/2007
1Thinness
06/2007
1Metabolic Diseases (Metabolic Disease)
12/2006
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
03/2006
1Myocardial Infarction
02/2006
1Hyperinsulinism (Hyperinsulinemia)
01/2006
1Chest Pain (Chest Pains)
12/2005
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2005
1Tissue Adhesions
12/2004
1Multiple Abnormalities
12/2004
1Hypoglycemia (Reactive Hypoglycemia)
08/2004
1Weight Gain
07/2004
1Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial)
04/2004
1Hypertension (High Blood Pressure)
07/2003
1Myocardial Ischemia (Ischemic Heart Diseases)
06/2003
1Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic)
07/2002

Drug/Important Bio-Agent (IBA)

7Glucose (Dextrose)FDA LinkGeneric
04/2007 - 07/2003
5AdiponectinIBA
01/2007 - 12/2004
4TropomyosinIBA
05/2007 - 01/2003
3Interleukin-6 (Interleukin 6)IBA
03/2008 - 07/2005
3Insulin (Novolin)FDA Link
02/2006 - 07/2003
3AcarboseFDA LinkGeneric
07/2003 - 06/2002
2CytokinesIBA
04/2008 - 12/2004
2CholesterolIBA
06/2007 - 03/2004
2C-Reactive ProteinIBA
01/2007 - 02/2006
2Lipase (Acid Lipase)IBA
09/2006 - 05/2004
2Ventricular MyosinsIBA
03/2006 - 12/2004
2PPAR gammaIBA
01/2006 - 10/2002
1Diacylglycerol KinaseIBA
02/2008
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2007
1GTP-Binding Proteins (G-Protein)IBA
06/2007
1PPAR alphaIBA
04/2007
1ZincIBA
03/2007
1Interleukin-1 (Interleukin 1)IBA
01/2007
1resveratrolIBA
12/2006
1SpermineIBA
10/2006
1SpermidineIBA
10/2006
1SqualeneIBA
07/2006
1myosin-binding protein CIBA
03/2006
1Dihydroxyphenylalanine (Dopa)IBA
01/2006
1AutoantibodiesIBA
12/2005
1oxidized low density lipoproteinIBA
12/2005
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
08/2005
1Advanced Glycosylation End ProductsIBA
04/2005
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
09/2004
1GlucokinaseIBA
08/2004
1Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
07/2004
1Lamin Type A (Lamin A)IBA
05/2004
1Transcription Factors (Transcription Factor)IBA
04/2004
1HomocysteineIBA
01/2004
1Sarcoglycans (beta Sarcoglycan)IBA
12/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2003
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2003
1Dietary Fats (Ghee)IBA
03/2003
1Cardiac MyosinsIBA
07/2002
1Carrier Proteins (Binding Protein)IBA
07/2002
1preproneuropeptide YIBA
03/2002
1Proline (L-Proline)FDA Link
03/2002
1LipidsIBA
03/2002
1Leucine (L-Leucine)FDA Link
03/2002
1Interleukin-1alpha (Interleukin 1 alpha)IBA
01/2002

Therapy/Procedure

1Stents
06/2003